Relapsed/Refractory Multiple Myeloma (RRMM)
Back to Video Library
Hey there, great course, right? Do you like this course?
All of the most interesting lessons further. In order to continue you just need to purchase it
Enroll course
Session sections
Section 1
1
Maximizing the beneļ¬ts for 1st Relapse RRMM Patients: Case Presentation
2
Optimizing the treatment of Len Refractory Patients
3
CANDOR: Carfilzomib, Dexamethasone, & Daratumumab Versus Carfilzomib & Dexamethasone for Relapsed Multiple Myeloma
4
Relapsed Multiple Myeloma: Case Presentation
5
Case of Relapsed Multiple Myeloma
6
How to Implement Endeavor & Arrow: Illustrated Case Based Discussion
7
RRMM: Panel Discussion
Questions
My Question
{{ comment.replies_count }}
Send
Load More
Back to Q&A List
Add Comment
{{ message }}
Send
CANDOR: Carfilzomib, Dexamethasone, & Daratumumab Versus Carfilzomib & Dexamethasone for Relapsed Multiple Myeloma
Lesson is locked. Please Buy course to proceed.
Optimizing the treatment of Len Refractory Patients
Completed
Relapsed Multiple Myeloma: Case Presentation
Questions
My Question